Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Seth M. Rubin is active.

Publication


Featured researches published by Seth M. Rubin.


Nature Reviews Molecular Cell Biology | 2013

Molecular mechanisms underlying RB protein function

Frederick A. Dick; Seth M. Rubin

Inactivation of the RB protein is one of the most fundamental events in cancer. Coming to a molecular understanding of its function in normal cells and how it impedes cancer development has been challenging. Historically, the ability of RB to regulate the cell cycle placed it in a central role in proliferative control, and research focused on RB regulation of the E2F family of transcription factors. Remarkably, several recent studies have found additional tumour-suppressor functions of RB, including alternative roles in the cell cycle, maintenance of genome stability and apoptosis. These advances and new structural studies are combining to define the multifunctionality of RB.


Proceedings of the National Academy of Sciences of the United States of America | 2001

Functionalized xenon as a biosensor

Megan M. Spence; Seth M. Rubin; Ivan E. Dimitrov; E. Janette Ruiz; David E. Wemmer; Alexander Pines; Shao Qin Yao; Feng Tian; Peter G. Schultz

The detection of biological molecules and their interactions is a significant component of modern biomedical research. In current biosensor technologies, simultaneous detection is limited to a small number of analytes by the spectral overlap of their signals. We have developed an NMR-based xenon biosensor that capitalizes on the enhanced signal-to-noise, spectral simplicity, and chemical-shift sensitivity of laser-polarized xenon to detect specific biomolecules at the level of tens of nanomoles. We present results using xenon “functionalized” by a biotin-modified supramolecular cage to detect biotin–avidin binding. This biosensor methodology can be extended to a multiplexing assay for multiple analytes.


Journal of Biological Chemistry | 2010

Methylation of the retinoblastoma tumor suppressor by SMYD2

Louis A. Saddic; Lisandra E. West; Aaron Aslanian; John R. Yates; Seth M. Rubin; Or Gozani; Julien Sage

The retinoblastoma tumor suppressor (RB) is a central cell cycle regulator and tumor suppressor. RB cellular functions are known to be regulated by a diversity of post-translational modifications such as phosphorylation and acetylation, raising the possibility that RB may also be methylated in cells. Here we demonstrate that RB can be methylated by SMYD2 at lysine 860, a highly conserved and novel site of modification. This methylation event occurs in vitro and in cells, and it is regulated during cell cycle progression, cellular differentiation, and in response to DNA damage. Furthermore, we show that RB monomethylation at lysine 860 provides a direct binding site for the methyl-binding domain of the transcriptional repressor L3MBTL1. These results support the idea that a code of post-translational modifications exists for RB and helps guide its functions in mammalian cells.


Nature | 2011

Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase

Mardo Kõivomägi; Ervin Valk; Rainis Venta; Anna Iofik; Martin Lepiku; Eva Rose M. Balog; Seth M. Rubin; David O. Morgan; Mart Loog

Multisite phosphorylation of proteins has been proposed to transform a graded protein kinase signal into an ultrasensitive switch-like response. Although many multiphosphorylated targets have been identified, the dynamics and sequence of individual phosphorylation events within the multisite phosphorylation process have never been thoroughly studied. In Saccharomyces cerevisiae, the initiation of S phase is thought to be governed by complexes of Cdk1 and Cln cyclins that phosphorylate six or more sites on the Clb5–Cdk1 inhibitor Sic1, directing it to SCF-mediated destruction. The resulting Sic1-free Clb5–Cdk1 complex triggers S phase. Here, we demonstrate that Sic1 destruction depends on a more complex process in which both Cln2–Cdk1 and Clb5–Cdk1 act in processive multiphosphorylation cascades leading to the phosphorylation of a small number of specific phosphodegrons. The routes of these phosphorylation cascades are shaped by precisely oriented docking interactions mediated by cyclin-specific docking motifs in Sic1 and by Cks1, the phospho-adaptor subunit of Cdk1. Our results indicate that Clb5–Cdk1-dependent phosphorylation generates positive feedback that is required for switch-like Sic1 destruction. Our evidence for a docking network within clusters of phosphorylation sites uncovers a new level of complexity in Cdk1-dependent regulation of cell cycle transitions, and has general implications for the regulation of cellular processes by multisite phosphorylation.


Trends in Biochemical Sciences | 2013

Deciphering the retinoblastoma protein phosphorylation code

Seth M. Rubin

Multisite phosphorylation modulates the function of regulatory proteins with complex signaling properties and outputs. The retinoblastoma tumor suppressor protein (Rb) is inactivated by cyclin-dependent kinase (Cdk) phosphorylation in normal and cancer cell cycles, so understanding the molecular mechanisms and effects of Rb phosphorylation is imperative. Rb functions in diverse processes regulating proliferation, and it has been speculated that multisite phosphorylation might act as a code in which discrete phosphorylations control specific activities. The idea of an Rb phosphorylation code is evaluated here in light of recent studies of Rb structure and function. Rb inactivation is discussed with an emphasis on how multisite phosphorylation changes Rb structure and associations with protein partners.


Journal of Biological Chemistry | 2010

Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding

Jason R. Burke; Alison J. Deshong; Jeffrey G. Pelton; Seth M. Rubin

Inactivation of the retinoblastoma protein (Rb) through phosphorylation is an important step in promoting cell cycle progression, and hyperphosphorylated Rb is commonly found in tumors. Rb phosphorylation prevents its association with the E2F transcription factor; however, the molecular basis for complex inhibition has not been established. We identify here the key phosphorylation events and conformational changes that occur in Rb to inhibit the specific association between the E2F transactivation domain (E2FTD) and the Rb pocket domain. Calorimetry assays demonstrate that phosphorylation of Rb reduces the affinity of E2FTD binding ∼250-fold and that phosphorylation at Ser608/Ser612 and Thr356/Thr373 is necessary and sufficient for this effect. An NMR assay identifies phosphorylation-driven conformational changes in Rb that directly inhibit E2FTD binding. We find that phosphorylation at Ser608/Ser612 promotes an intramolecular association between a conserved sequence in the flexible pocket linker and the pocket domain of Rb that occludes the E2FTD binding site. We also find that phosphorylation of Thr356/Thr373 inhibits E2FTD binding in a manner that requires the Rb N-terminal domain. Taken together, our results suggest two distinct mechanisms for how phosphorylation of Rb modulates association between E2FTD and the Rb pocket and describe for the first time a function for the structured N-terminal domain in Rb inactivation.


Journal of Molecular Biology | 2002

Detection and characterization of xenon-binding sites in proteins by 129Xe NMR spectroscopy.

Seth M. Rubin; Seok-Yong Lee; E. Janette Ruiz; Alexander Pines; David E. Wemmer

Xenon-binding sites in proteins have led to a number of applications of xenon in biochemical and structural studies. Here we further develop the utility of 129Xe NMR in characterizing specific xenon-protein interactions. The sensitivity of the 129Xe chemical shift to its local environment and the intense signals attainable by optical pumping make xenon a useful NMR reporter of its own interactions with proteins. A method for detecting specific xenon-binding interactions by analysis of 129Xe chemical shift data is illustrated using the maltose binding protein (MBP) from Escherichia coli as an example. The crystal structure of MBP in the presence of 8atm of xenon confirms the binding site determined from NMR data. Changes in the structure of the xenon-binding cavity upon the binding of maltose by the protein can account for the sensitivity of the 129Xe chemical shift to MBP conformation. 129Xe NMR data for xenon in solution with a number of cavity containing phage T4 lysozyme mutants show that xenon can report on cavity structure. In particular, a correlation exists between cavity size and the binding-induced 129Xe chemical shift. Further applications of 129Xe NMR to biochemical assays, including the screening of proteins for xenon binding for crystallography are considered.


Nature Structural & Molecular Biology | 2013

Multisite phosphorylation networks as signal processors for Cdk1

Mardo Kõivomägi; Mihkel Örd; Anna Iofik; Ervin Valk; Rainis Venta; Ilona Faustova; Rait Kivi; Eva Rose M. Balog; Seth M. Rubin; Mart Loog

The order and timing of cell-cycle events is controlled by changing substrate specificity and different activity thresholds of cyclin-dependent kinases (CDKs). However, it is not understood how a single protein kinase can trigger hundreds of switches in a sufficiently time-resolved fashion. We show that cyclin–Cdk1–Cks1–dependent phosphorylation of multisite targets in Saccharomyces cerevisiae is controlled by key substrate parameters including distances between phosphorylation sites, distribution of serines and threonines as phosphoacceptors and positioning of cyclin-docking motifs. The component mediating the key interactions in this process is Cks1, the phosphoadaptor subunit of the cyclin–Cdk1–Cks1 complex. We propose that variation of these parameters within networks of phosphorylation sites in different targets provides a wide range of possibilities for differential amplification of Cdk1 signals, thus providing a mechanism to generate a wide range of thresholds in the cell cycle.


Cell | 2013

Rif1 and Rif2 Shape Telomere Function and Architecture through Multivalent Rap1 Interactions

Tianlai Shi; Richard D. Bunker; Stefano Mattarocci; Cyril Ribeyre; Mahamadou Faty; Heinz Gut; Ulrich Rass; Seth M. Rubin; David Shore; Nicolas H. Thomä

Yeast telomeres comprise irregular TG₁₋₃ DNA repeats bound by the general transcription factor Rap1. Rif1 and Rif2, along with Rap1, form the telosome, a protective cap that inhibits telomerase, counteracts SIR-mediated transcriptional silencing, and prevents inadvertent recognition of telomeres as DNA double-strand breaks. We provide a molecular, biochemical, and functional dissection of the protein backbone at the core of the yeast telosome. The X-ray structures of Rif1 and Rif2 bound to the Rap1 C-terminal domain and that of the Rif1 C terminus are presented. Both Rif1 and Rif2 have separable and independent Rap1-binding epitopes, allowing Rap1 binding over large distances (42-110 Å). We identify tetramerization (Rif1) and polymerization (Rif2) modules that, in conjunction with the long-range binding, give rise to a higher-order architecture that interlinks Rap1 units. This molecular Velcro relies on Rif1 and Rif2 to recruit and stabilize Rap1 on telomeric arrays and is required for telomere homeostasis in vivo.


The EMBO Journal | 2012

An N-terminal acidic region of Sgs1 interacts with Rpa70 and recruits Rad53 kinase to stalled forks

Anna Maria Hegnauer; Nicole Hustedt; Kenji Shimada; Brietta L. Pike; Markus Vogel; Philipp Amsler; Seth M. Rubin; Fred W. van Leeuwen; Aude Guénolé; Haico van Attikum; Nicolas H. Thomä; Susan M. Gasser

DNA replication fork stalling poses a major threat to genome stability. This is counteracted in part by the intra‐S phase checkpoint, which stabilizes arrested replication machinery, prevents cell‐cycle progression and promotes DNA repair. The checkpoint kinase Mec1/ATR and RecQ helicase Sgs1/BLM contribute synergistically to fork maintenance on hydroxyurea (HU). Both enzymes interact with replication protein A (RPA). We identified and deleted the major interaction sites on Sgs1 for Rpa70, generating a mutant called sgs1‐r1. In contrast to a helicase‐dead mutant of Sgs1, sgs1‐r1 did not significantly reduce recovery of DNA polymerase α at HU‐arrested replication forks. However, the Sgs1 R1 domain is a target of Mec1 kinase, deletion of which compromises Rad53 activation on HU. Full activation of Rad53 is achieved through phosphorylation of the Sgs1 R1 domain by Mec1, which promotes Sgs1 binding to the FHA1 domain of Rad53 with high affinity. We propose that the recruitment of Rad53 by phosphorylated Sgs1 promotes the replication checkpoint response on HU. Loss of the R1 domain increases lethality selectively in cells lacking Mus81, Slx4, Slx5 or Slx8.

Collaboration


Dive into the Seth M. Rubin's collaboration.

Top Co-Authors

Avatar

David E. Wemmer

National Institute of Standards and Technology

View shared research outputs
Top Co-Authors

Avatar

Alexander Pines

National Institute of Standards and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Janette Ruiz

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jason R. Burke

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Larisa Litovchick

Virginia Commonwealth University

View shared research outputs
Top Co-Authors

Avatar

Thomas J. Lowery

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Tyler J. Liban

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge